Catalent introduces cryogenic capabilities to support growing demand for cell and gene therapy in Philadelphia
As part of a newly made investment, pharmaceuticals company Catlent has introduced cryogenic storage at its clinical supply services facility in Philadelphia to support sponsors developing cell and gene therapies.